Patents Assigned to Sanofi (China) Investment Co., Ltd. Shanghai Branch
  • AGR2 blocking antibody and use thereof
    Patent number: 9574012
    Abstract: Disclosed is an AGR2 blocking monoclonal antibody, and in particular, a humanized monoclonal antibody for blocking AGR2. Also disclosed is a pharmaceutical composition containing the antibody and a method for preparing the same, and a use of the antibody in blocking tumor growth and metastasis.
    Type: Grant
    Filed: July 5, 2012
    Date of Patent: February 21, 2017
    Assignees: Sanofi (China) Investment Co., Ltd. Shanghai Branch, Shanghai Jiao Tong University
    Inventors: Dawei Li, Zhenghua Wu, Hao Guo, Qi Zhu, Dhahiri S. Mashausi